DE69329281T2 - Pyridinderivate als Hydroxylase- und Lyase-Inhibitoren - Google Patents

Pyridinderivate als Hydroxylase- und Lyase-Inhibitoren

Info

Publication number
DE69329281T2
DE69329281T2 DE69329281T DE69329281T DE69329281T2 DE 69329281 T2 DE69329281 T2 DE 69329281T2 DE 69329281 T DE69329281 T DE 69329281T DE 69329281 T DE69329281 T DE 69329281T DE 69329281 T2 DE69329281 T2 DE 69329281T2
Authority
DE
Germany
Prior art keywords
pct
hydroxylase
pyridine derivatives
sec
lyase inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69329281T
Other languages
English (en)
Other versions
DE69329281D1 (de
Inventor
Ferdinand Chan
Michael Jarman
Gerard Andrew Potter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BTG International Ltd
Original Assignee
BTG International Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929210489A external-priority patent/GB9210489D0/en
Priority claimed from GB929223738A external-priority patent/GB9223738D0/en
Application filed by BTG International Ltd filed Critical BTG International Ltd
Publication of DE69329281D1 publication Critical patent/DE69329281D1/de
Application granted granted Critical
Publication of DE69329281T2 publication Critical patent/DE69329281T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/46—Oxygen atoms
    • C07D213/50—Ketonic radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/28—Antiandrogens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/55—Acids; Esters

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Reproductive Health (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Cosmetics (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE69329281T 1992-05-15 1993-04-29 Pyridinderivate als Hydroxylase- und Lyase-Inhibitoren Expired - Fee Related DE69329281T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB929210489A GB9210489D0 (en) 1992-05-15 1992-05-15 Heterocyclic compounds,their preparation and pharmaceutical use
GB929223738A GB9223738D0 (en) 1992-11-12 1992-11-12 Heterocyclic compounds,their preparation and pharmaceutical use
PCT/GB1993/000890 WO1993023375A1 (en) 1992-05-15 1993-04-29 Substituted pyridines, their preparation and pharmaceutical use

Publications (2)

Publication Number Publication Date
DE69329281D1 DE69329281D1 (de) 2000-09-28
DE69329281T2 true DE69329281T2 (de) 2001-03-15

Family

ID=26300892

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69329281T Expired - Fee Related DE69329281T2 (de) 1992-05-15 1993-04-29 Pyridinderivate als Hydroxylase- und Lyase-Inhibitoren

Country Status (15)

Country Link
US (1) US5595995A (de)
EP (1) EP0640072B1 (de)
JP (1) JPH07506588A (de)
KR (1) KR100235976B1 (de)
AT (1) ATE195728T1 (de)
AU (1) AU673837B2 (de)
CA (1) CA2134563A1 (de)
DE (1) DE69329281T2 (de)
ES (1) ES2149817T3 (de)
IL (1) IL105666A (de)
MX (1) MX9302833A (de)
NO (1) NO302069B1 (de)
NZ (1) NZ252717A (de)
TW (1) TW223631B (de)
WO (1) WO1993023375A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2159087T3 (es) * 1996-05-28 2001-09-16 Pfizer Oxindoles sustituidos con adamantilo como agentes farmaceuticos.
US7795468B2 (en) * 2001-01-19 2010-09-14 Chevron U.S.A. Inc. Functionalized higher diamondoids
US6864264B1 (en) * 2002-08-20 2005-03-08 Gloria L. Anderson 1-adamantyl chalcones for the treatment of proliferative disorders
JP2006160605A (ja) * 2003-07-09 2006-06-22 Nippon Kayaku Co Ltd 新規酵素阻害剤
JP2008007404A (ja) * 2004-10-08 2008-01-17 Nippon Kayaku Co Ltd 新規ピリジン誘導体
RU2447060C2 (ru) * 2005-06-17 2012-04-10 Эпоуджи Биотекнолоджи Корпорейшн Ингибиторы сфингозинкиназы
GB0803494D0 (en) * 2008-02-26 2008-04-02 Sterix Ltd Compound

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3971797A (en) * 1973-06-15 1976-07-27 Merck & Co., Inc. S,S'-bis(pyridylmethyl)-carbonodithioates
US4797411A (en) * 1986-07-18 1989-01-10 Farmitalia Carlo Erba S.P.A. Cycloalkyl-substituted 4-pyridyl derivatives and use as aromatase inhibitors
DE4018260A1 (de) * 1990-06-07 1991-12-12 Basf Ag Derivate des (beta)-picolins und diese enthaltende pflanzenschutzmittel

Also Published As

Publication number Publication date
EP0640072A1 (de) 1995-03-01
AU673837B2 (en) 1996-11-28
KR100235976B1 (ko) 1999-12-15
US5595995A (en) 1997-01-21
EP0640072B1 (de) 2000-08-23
DE69329281D1 (de) 2000-09-28
CA2134563A1 (en) 1993-11-25
NO302069B1 (no) 1998-01-19
KR950701620A (ko) 1995-04-28
JPH07506588A (ja) 1995-07-20
ES2149817T3 (es) 2000-11-16
TW223631B (de) 1994-05-11
AU4267493A (en) 1993-12-13
NO944332L (no) 1994-11-14
NO944332D0 (no) 1994-11-14
NZ252717A (en) 1996-05-28
IL105666A (en) 1999-09-22
WO1993023375A1 (en) 1993-11-25
MX9302833A (es) 1993-11-01
ATE195728T1 (de) 2000-09-15
IL105666A0 (en) 1993-09-22

Similar Documents

Publication Publication Date Title
SE8704599L (sv) Teobrominderivat
TR200102109T2 (tr) Ras-farnesiltransferazı inhibitörü ve sülfobütileter-7-ß-siklodekstrin veya 2-hidroksipropil-ß-siklodekstrin kompleksi ve metod.
GB9300194D0 (en) Piperazine derivatives
DE69329281T2 (de) Pyridinderivate als Hydroxylase- und Lyase-Inhibitoren
ES2184318T3 (es) 6-alquilfenantridinas sustituidas.
MY129935A (en) Dihydropyridine derivatives useful in antitumor therapy
DE69214827T2 (de) Tetrazolamide als acat inhibitoren
IL108387A0 (en) Optically active Beta-aminoalkoxyborane complex and its uses in organic synthesis
DE69431471T2 (de) Amidderivate als 5-HT1A-Liganden
TW325463B (en) 4-Aminobenzoylguanidine-derivatives
DE69526097D1 (de) Bicyclische carboxamide als 5-ht1a rezeptoren liganden
DE69131353T2 (de) Indolderivate
TW326041B (en) Pyridazinone derivatives, their production process and their use for inhibition of platelet aggregation
DK0673368T3 (da) Hidtil ukendte nicotinsyreestere
DE69402021T2 (de) Verzweigte aminooxy-amino-alkan-derivate als ornithin-decarboxylase inhibitoren

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee